Madrigal Pharmaceuticals(MDGL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MDGL Madrigal Pharmaceuticals

Market Closed 10-09 16:00:00 EDT

471.75

-5.16

-1.08%

盘后471.75

+0.000.00%

19:30 EDT

High483.64	Low470.53	Vol313.00K
Open477.48	D1 Closing476.91	Amplitude2.75%
Mkt Cap10.88B	Tradable Cap6.47B	Total Shares23.06M
T/O148.73M	T/O Rate2.28%	Tradable Shares13.73M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MDGL","market":"US","secType":"STK","nameCN":"Madrigal Pharmaceuticals","latestPrice":471.75,"timestamp":1791576000000,"preClose":476.91,"halted":0,"volume":312998,"hourTrading":{"tag":"盘后","latestPrice":471.75,"preClose":471.75,"latestTime":"19:30 EDT","volume":3164,"amount":1492878.96,"timestamp":1791588605083,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.01081965150657362,"floatShares":13725000,"shares":23055522,"eps":-14.216436,"marketStatus":"Market Closed","change":-5.16,"latestTime":"10-09 16:00:00 EDT","open":477.48,"high":483.635,"low":470.53,"amount":148733416.33066,"amplitude":0.027479,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-14.216436,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":476.91,"postHourTrading":{"tag":"盘后","latestPrice":471.75,"preClose":471.75,"latestTime":"19:30 EDT","volume":3164,"amount":1492878.96,"timestamp":1791588605083,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.045687131048965,"impliedVol":0.6002,"impliedVolPercentile":0.761},"requestUrl":"/m/hq/s/MDGL/wiki","defaultTab":"wiki","newsList":[{"id":"2673056626","title":"Madrigal Announces Publication in the Journal of Hepatology Demonstrating Consistent Rezdiffra Efficacy Across Common MASH Genetic Risk Variants","url":"https://stock-news.laohu8.com/highlight/detail?id=2673056626","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673056626?lang=en_us&edition=fundamental","pubTime":"2026-10-06 20:00","pubTimestamp":1791288000,"startTime":"0","endTime":"0","summary":"Secondary analysis of the Phase 3 MAESTRO-NASH trial demonstrated Rezdiffra improved histology and MRI-PDFF across common genetic variants associated with MASH progression CONSHOHOCKEN, Pa., Oct.  06,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/06/3375437/0/en/madrigal-announces-publication-in-the-journal-of-hepatology-demonstrating-consistent-rezdiffra-efficacy-across-common-mash-genetic-risk-variants.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","MDGL","BK4139","NOBL","BK4550","VHT","BK4588","COAL","TCAF","BK4006","CGCV","HCC","IXJ","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671270252","title":"Barclays Keeps Their Buy Rating on Madrigal Pharmaceuticals (MDGL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671270252","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671270252?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:25","pubTimestamp":1790760334,"startTime":"0","endTime":"0","summary":"Barclays analyst Eliana Merle maintained a Buy rating on Madrigal Pharmaceuticals today and set a price target of $962.00. According to TipRanks, M...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-keeps-their-buy-rating-on-madrigal-pharmaceuticals-mdgl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-keeps-their-buy-rating-on-madrigal-pharmaceuticals-mdgl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670947607","title":"HCA, Tenet, CoreWeave, Microsoft, Madrigal Trending With Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2670947607","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670947607?lang=en_us&edition=fundamental","pubTime":"2026-09-26 17:01","pubTimestamp":1790413267,"startTime":"0","endTime":"0","summary":"Analysts are intrested in these 5 stocks: ( ($HCA) ), ( ($THC) ), ( ($CRWV) ), ( ($MSFT) ) and ( ($MDGL) ). Here is a breakdown of their recent","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/hca-tenet-coreweave-microsoft-madrigal-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/hca-tenet-coreweave-microsoft-madrigal-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0690374961.EUR","IE00B5TLWC47.USD","LU0133085943.USD","SGXZ51526630.SGD","EFIV","LU0985489474.SGD","LU0894486033.HKD","LU1564329032.USD","LU2471134879.HKD","MSFL","IE00BMPRXR70.SGD","SG9999015952.SGD","LU0320765059.SGD","IE00BJTD4N35.SGD","LU1645745479.HKD","TDIV","LU1244550494.USD","LU2092937221.SGD","LU0898699433.AUD","LU0528227936.USD","LU0157215616.USD","LU2362540622.SGD","LU0080751232.USD","LU0557290698.USD","LU1815333072.USD","GB00B4QBRK32.GBP","LU0426412945.USD","BK4534","HCA","LU0095938881.EUR","LU0354030511.USD","LU2148611432.USD","LU0068578508.USD","LU0784385170.HKD","LU1043141123.HKD","IE0009G5SDU7.USD","LU0353189763.USD","LU2417539215.USD","LU0174119429.USD","LU1923623000.USD","SG9999004303.SGD","IE00B19Z8W00.USD","LU2552382215.SGD","LU0289960550.SGD","LU2357305700.SGD","LU2168564222.USD","LU1989764664.SGD","LU2054465674.USD","LU0784384876.USD","LU0726765562.USD","IE0004086264.USD","IE00B3S45H60.SGD","LU2462591277.SGD","LU2271345857.HKD","LU0476273544.USD","BK4139","LU0823417653.USD","LU0708995401.HKD","LU2237957902.USD","LU0077335932.USD","BK4554","LU1585245621.USD","LU1935042991.SGD","IE00BHPRN162.USD","HK0000819398.USD","LU1064131342.USD","LU0965509101.SGD","LU1974910355.USD","LU1988902786.USD","LU2023250843.SGD","LU2028103732.USD","LU0061474960.USD","LU2250418816.HKD","LU1116320737.USD","LU2125909593.SGD","LU1236620750.USD","SG9999014575.USD","LU0225283273.USD","IE000KEQY171.SGD","IE00BFXG0V08.USD","LU1852331112.SGD","LU1979441026.SGD","IE00B1XK9C88.USD","LU2092937148.SGD","LU0107464264.USD","LU1221951129.SGD","SG9999014906.USD","LU0672654240.SGD","LU0823417737.USD","LU0072461881.USD","LU2347655156.SGD","LU2458330243.SGD","SNPE","LU0069063385.USD","LU2168564495.EUR","LU0128525929.USD","LU1868837136.USD","LU0787776722.HKD","LU0109391861.USD","LU0964807845.USD","LU0466842654.USD","LU1582986433.USD","LU2750360997.AUD","IE00BN29S564.USD","IE00B775SV38.USD","LU2860962120.EUR","LU1934455277.USD","LU2506951958.HKD","LU0316494557.USD","LU2430703095.HKD","LU1868837300.USD","LU0879622024.SGD","XLK","LU1153585028.USD","GB00BDT5M118.USD","LU1732800096.USD","HK0000914660.USD","LU1323610961.USD","HK0000304805.HKD","LU1815336760.USD","MSFT","SG9999015341.SGD","BK4185","IHF","LU0079474960.USD","LU0267386448.USD","LU1720051108.HKD","LU0130103400.USD","LU0175139822.USD","LU2047632596.USD","LU2077746001.SGD","LU2750360641.GBP","LU0097036916.USD","LU1670711040.USD","MDGL","LU0545039389.USD","SG9999001424.SGD","LU0345770308.USD","LU1642822529.SGD","LU2954938101.SGD","LU1435385759.SGD","LU2236285917.USD","LU2355687059.USD","BK4503","LU1236620834.HKD","LU1670628061.USD","MSFX","IE00BFSS7M15.SGD","IE00BDCRKT87.USD","IE000F7OJYX1.SGD","BK4576","LU0648001328.SGD","IE0000B7K699.USD","LU1670711123.USD","LU1232071149.USD","LU2764262908.HKD","IE0034235303.USD","IE00BKPKM429.USD","LU0312595415.SGD","IE0005OL40V9.USD","LU1989773731.SGD","LU1400636657.SGD","LU1043141396.HKD","LU2360108059.USD","LU1670627923.USD","BK4587","LU1551013425.SGD","LU0048584097.USD","LU0208291251.USD","LU1316542783.SGD","SG9999014898.SGD","IE00BLSP4239.USD","LU0256863902.USD","LU0861579265.USD","LU2361044865.SGD","LU2023250330.USD","LU2381873111.SGD","LU0823434740.USD","LU2413666699.HKD","LU2275660780.HKD","LU0187121727.USD","BK4566","LU0203345920.USD","LU1267930573.SGD","LU0820561909.HKD","LU1670756490.USD","LU0265550359.USD","LU1923622614.USD","LU0894485498.HKD","LU1935042215.USD","LU2452424414.USD","IE000SO60NU8.SGD","TTXU","LU1571399168.USD","LU2097344357.USD","LU2461242641.AUD","SG9999001077.SGD","IE00BJJMRY28.SGD","LU0820562030.AUD","LU1244550221.USD","LU2462591350.SGD","LU2286300806.USD","BK4525","SG9999015986.USD","MSFC","LU1623119135.USD","LU2362541513.USD","LU1366333091.USD","BK4116","LU1861127337.USD","LU2106854487.HKD","SG9999014039.USD","LU0310799852.SGD","LU0690374615.EUR","IE00B19Z9505.USD","LU0683600562.USD","LU2237443622.USD","LU0158827781.USD","LU1267930490.SGD","IE00BZ1G4Q59.USD","LU0289739343.SGD","LU1069344957.HKD","SG9999002224.SGD","LU1429558221.USD","LU1989772840.SGD","IGV","LU0957791311.USD","LU0788109477.HKD","LU1127390331.HKD","LU2463028550.USD","LU0096362180.USD","IE00BFXG1179.USD","BK4528","LU1150488135.SGD","LU2298321311.HKD","BK4612","CRWU","LU0211327993.USD","OGIG","LU1119994496.HKD","IE000ITXATA3.USD","LU0256863811.USD","IE000MB6IJN5.SGD","LU1032955483.USD","LU0143551892.USD","LU3102509885.SGD","LU1803068979.SGD","LU0342679015.USD","LU2087625088.SGD","LU0210536198.USD","LU0198837287.USD","LU0689472784.USD","BK4598","LU0417517546.SGD","LU2041044095.USD","LU1074936037.SGD","LU1582986359.USD","LU1989764748.USD","LU2063271972.USD","LU2543165471.USD","LU2505996509.AUD","LU0444971666.USD","HK0000532082.HKD","LU0210528500.USD","LU1046421795.USD","LU1181866309.USD","BK4579","BK4097","LU2108987350.USD","LU2471134796.USD","LU0648000940.SGD","LU2089283258.USD","LU2237438978.USD","LU1914381329.SGD","LU2487616109.SGD","LU1202635105.USD","IE00BDRTCR15.USD","LU1235295455.SGD","LU2083900584.USD","LU2168563687.JPY","LU0823421333.USD","LU2089284900.SGD","LU1069347547.HKD","LU0757359368.USD","LU0949170772.SGD","LU1267930730.SGD","LU1778281490.HKD","IE0001KFT4U8.USD","IE0004445015.USD","LU0323240290.USD","LU1066051225.USD","SGXZ80539844.SGD","LU2756315318.SGD","LU0784383803.USD","LU2764263039.SGD","LU2360032135.SGD","CORD","LU2360106780.USD","LU0950375773.USD","SG9999014914.USD","IE000W1ABFV2.USD","LU0348723411.USD","LU1267930813.SGD","LU0345774631.USD","BK4533","LU0878866978.SGD","LU2896262040.SGD","BK4538","LU1116320901.HKD","LU1814569148.SGD","LU1868836914.USD","LU2125154778.USD","LU2505996681.GBP","LU0320765489.SGD","LU2420271590.USD","LU2065169927.USD","LU2999663052.SGD","LU2602419157.SGD","IE00B4YYXB79.USD","LU1366192091.USD","LU2433249047.HKD","LU0511384066.AUD","LU1035773651.USD","LU0109392836.USD","IE000M9KFDE8.USD","LU2087621335.USD","LU1935042488.USD","LU2720916845.USD","LU0210533765.USD","LU0323239441.USD","LU2065171311.SGD","LU1803068623.USD","CRWV","LU1732799900.SGD","LU1340139317.AUD","LU0061474705.USD","LU0390134368.USD","LU1150488218.USD","LU2065171402.SGD","LU2168564065.EUR","LU0114720955.EUR","LU0203201768.USD","LU1868836757.USD","LU1201861165.SGD","LU1430594728.SGD","LU2324357040.USD","LU0081259029.USD","LU0345768153.USD","LU2237443465.HKD","LU1880398554.USD","LU2242650005.HKD","LU2403377893.USD","SGXZ99366536.SGD","LU0154236417.USD","LU2092627202.USD","LU1989763005.USD","IE0034235188.USD","LU2456880835.USD","LU1301847155.USD","BK4535","LU0302445910.USD","LU1861558580.USD","LU1839511570.USD","MSFW","LU0980610538.SGD","LU2097829019.USD","LU2133065610.SGD","LU1066053197.SGD","BK4577","SG9999015945.SGD","LU1037948897.HKD","IE00B19Z8X17.USD","LU0345769631.USD","SG9999015978.USD","SG9999017495.SGD","LU0149725797.USD","LU1582987324.SGD","SGXZ81514606.USD","LU2244417387.USD","IE00BQXX3C00.GBP","HK0000304797.USD","LU0251132253.USD","CRWG","LU0094547139.USD","LU1983260115.SGD","LU2168564149.EUR","LU0310800379.SGD","LU1059921491.USD","LU0889565833.HKD","LU2065170008.USD","IE0004091025.USD","LU0006306889.USD","LU0070302665.USD","LU2102340556.USD","LU0082616367.USD","IE00BMPRXQ63.HKD","LU2242649171.HKD","LU2111349929.HKD","IE00BSNM7G36.USD","LU0130102774.USD","LU1334329650.SGD","LU2023251221.USD","LU0456855351.SGD","IE0003U64NQ7.SGD","SG9999000418.SGD","LU0345770993.USD","LU1674673428.USD","IE00BKVL7J92.USD","LU0444973449.USD","LU0757359954.USD","LU1121112475.USD","SG9999014005.SGD","LU0289941410.SGD","LU1674673691.USD","LU0070217475.USD","MSFY","LU2462157665.USD","LU2471134523.USD","IE00BYXW3230.USD","LU1917777945.USD","LU1145028129.USD","LU2413666426.HKD","LU2347655073.USD","LU0215105999.USD","LU2491049909.HKD","LU1951200564.SGD","IE00B1BXHZ80.USD","LU2592432038.USD","LU2430703178.SGD","CRWX","LU1633808545.USD","LU1823568750.SGD","LU1261432733.SGD","LU0011850046.USD","SGXZ23171101.USD","LU2211815571.USD","LU1691799644.USD","BK4581","LU1935043023.USD","IE00BBT3K403.USD","LU1084165304.USD","LU0871640123.AUD","LU1935043452.HKD","LU2458330169.SGD","LU0124676726.USD","SG9999014559.SGD","LU2764263203.CNY","LU0323591593.USD","LU0494093205.USD","SG9999014567.USD","BK4527","LU0792757196.USD","LU0889566641.SGD","LU0708994859.HKD","BK4588","LU1934455194.USD","LU0138981039.USD","MSFU","IE00BMPRXN33.USD","IE0009356076.USD","LU0882574055.USD","LU1506573853.SGD","IE00B7KXQ091.USD","LU1720051017.SGD","LU0029864427.USD","LU0433182093.SGD","LU2210150020.SGD","SG9999018857.SGD","IE000WAW04H5.SGD","CWII","LU0859254822.USD","LU0203347892.USD","LU1721428933.USD","LU0882574139.USD","LU2491050071.SGD","LU0724617625.USD","LU2506951875.HKD","CNEQ","LU0170899867.USD","LU2210149790.SGD","LU0345774391.USD","IE00BJJMRX11.SGD","LU0912757837.SGD","LU0354030438.USD","LU0719512351.SGD","LU1496350502.SGD","IE000YTNTUN2.SGD","IE00B775H168.HKD","GB00B4LPDJ14.GBP","IE00BLSP4452.SGD","LU0096364046.USD","LU2362541273.HKD","LU0347712357.USD","LU2756315664.SGD","TYLG","LU0738911758.USD","MSFO","LU0127658192.USD","LU0106261372.USD","LU1244550577.SGD","LU2637965513.SGD","SG9999002232.USD","LU1564329461.SGD","LU0345769128.USD","LU0943347566.SGD","LU1670710661.SGD","LU1861559042.SGD","LU0171293334.USD","LU2237443549.SGD","LU2237443978.SGD","LU0203202063.USD","LU1228905037.USD","LU0823421416.USD","LU0238689110.USD","LU1280957306.USD","LU1066051811.HKD","LU0963586101.USD","LU0965508806.USD","LU0820561818.USD","SMSFTmain","IE00B3SWFQ91.USD","LU0949170426.SGD","LU2264538146.SGD","LU0266013472.USD","LU0985320562.USD","LU2279689827.SGD","LU1718418525.SGD","LU2552382132.HKD","LU0994945656.USD","LU0308772762.SGD","LU0426417589.USD","LU0234572021.USD","LU2326559502.SGD","LU2125909247.SGD","HK0000914686.HKD","LU2430703251.USD","GAMR","IE00BWXC8680.SGD","LU0689626769.HKD","LU1868836591.USD","LU2506952170.USD","BK4548","BK4543","LU1188199696.SGD","LU2552382058.USD","LU2023250504.SGD","LU1951198990.SGD","LU0061475181.USD","LU2746668974.SGD","NULC","VGT","LU2213496289.HKD","BK4532","LU0642271901.SGD","LU0957808578.USD","IE00BFSS8Q28.SGD","LU2404859667.USD","LU0472753341.HKD","LU1791710400.SGD","LU0965509010.AUD","LU0057025933.USD","LU1066051498.USD","BK4516","LU1880398471.USD","LU0053666078.USD","IE00B5949003.HKD","ROM","LU2506952097.USD","LU0661504455.SGD","LU0823434583.USD","LU0784385840.USD","LU0314104364.USD","LU1235294995.USD","LU1400636574.HKD","SPTE","LU2361045086.USD","IE00BKDWB100.SGD","LU0960925559.SGD","SG9999015358.SGD","LU2746668461.USD","IE00BN8TJ469.HKD","LU1697837992.HKD","SG9999014542.SGD","IE00BK4W5M84.HKD","LU1934455863.HKD","LU0211331839.USD","CMAG","LU2125154935.USD","SGXZ31699556.SGD","SG9999018865.SGD","LU0553294199.USD","IE00B4JS1V06.HKD","IE00BK4W5L77.USD","LU2237443895.HKD","LU1935043536.SGD","LU1201861249.SGD","LU1989772923.USD","LU1489326972.SGD","LU0353189680.USD","LU2097344431.USD","BK4504","LU0162691827.USD","LU0868494617.USD","BK4567","LU2237443382.USD","IE000BZT7R73.USD","LU1496350171.SGD","IE0034235295.USD","IE00BJLML261.HKD","LU1582987597.SGD","LU0056508442.USD","LU0211328371.USD","LU2237957811.SGD","LU0234570918.USD","LU0276348264.USD","LU1400636491.USD","LU0314106906.USD","LU1548497426.USD","LU0265550946.USD","IXN","LU1551013342.USD","LU0795875086.SGD","SG9999014013.SGD","LU2191332357.HKD","BK4550","IE00BQXX3F31.USD","LU1196500208.SGD","LU1804176565.USD","LU2100268510.USD","LU0345768740.USD","LU1228905540.USD","MSFD","BK4592","THC","SG9999014880.SGD","CWVX","LU0545562505.USD","LU0072462426.USD","LU0965509283.SGD","LU2095319765.USD","LU1035775433.USD","LU1712237335.SGD","LU2404859741.USD","FTEC","LU0289961442.SGD","LU1037948541.HKD","LU2247934214.USD","SG9999014021.USD","LU0795875169.SGD","LU1629891620.HKD","LU0640476718.USD","LU1003077747.HKD","LU1564329115.USD","LU1032466523.USD","IE00BYQQ9H92.USD","IE00BQXX3D17.EUR","LU2357627491.SGD","LU2361044949.HKD","LU1670710588.SGD","LU2471134952.CNY","LU1221951046.USD","LU2491050154.USD","LU1791710582.SGD","IE0004445239.USD","LU0158827948.USD","LU0395794307.EUR","BK4585","IE00BJTD4V19.USD","LU1564329628.SGD","LU2265009873.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669498085","title":"Madrigal Pharmaceuticals Price Target Announced at $704.00/Share by Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2669498085","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669498085?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:50","pubTimestamp":1790254200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MDGL/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669651384","title":"Madrigal Pharmaceuticals resumed with a Buy at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2669651384","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669651384?lang=en_us&edition=fundamental","pubTime":"2026-09-24 16:50","pubTimestamp":1790239853,"startTime":"0","endTime":"0","summary":"Goldman Sachs resumed coverage of Madrigal Pharmaceuticals (MDGL) with a Buy rating and $704 price target Goldman resumed coverage of the biotechno...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/madrigal-pharmaceuticals-resumed-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/madrigal-pharmaceuticals-resumed-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443978.SGD","IE0004086264.USD","BK4504","BK4127","LU2471134952.CNY","LU1868837300.USD","LU2750360997.AUD","LU1868836757.USD","LU1804176565.USD","LU1791807156.HKD","LU0048573561.USD","LU0942090050.USD","LU0868494617.USD","IE0034235188.USD","LU0742534661.SGD","LU1894683348.USD","MDGL","BK4516","IE00BSNM7G36.USD","LU0251131958.USD","LU2237438978.USD","LU2750360641.GBP","LU2237443622.USD","IE0004091025.USD","LU0345770308.USD","IE00BFXG1179.USD","LU1894683264.USD","LU0210536198.USD","LU2265009873.SGD","LU0345770993.USD","LU2237443549.SGD","LU0096364046.USD","LU2471134523.USD","BK4139","GSX","IE0002270589.USD","IE00B19Z3581.USD","LU2237443465.HKD","BK4588","LU1668664300.SGD","LU1868836914.USD","LU2471134796.USD","LU2471134879.HKD","LU2896262040.SGD","LU0061475181.USD","LU1868837136.USD","LU1144417596.USD","BK4552","IE00B19Z3B42.SGD","LU0868494708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669210772","title":"Citigroup Initiates Madrigal Pharmaceuticals at Buy With $725 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2669210772","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669210772?lang=en_us&edition=fundamental","pubTime":"2026-09-23 18:42","pubTimestamp":1790160140,"startTime":"0","endTime":"0","summary":"Madrigal Pharmaceuticals (MDGL) has an average rating of buy and mean price target of $678.18, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MDGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669102659","title":"Madrigal Pharmaceuticals, Inc. : Citigroup Initiates Coverage with Buy Rating; Price Target $725","url":"https://stock-news.laohu8.com/highlight/detail?id=2669102659","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669102659?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:55","pubTimestamp":1790157353,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F0CS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","BK4139","BK4588","MDGL","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669510105","title":"Madrigal Pharmaceuticals initiated with a Buy at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2669510105","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669510105?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:10","pubTimestamp":1790154620,"startTime":"0","endTime":"0","summary":"Citi initiated coverage of Madrigal Pharmaceuticals (MDGL) with a Buy rating and $725 price target The firm believes the company’s Rezdiffra is bei...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/madrigal-pharmaceuticals-initiated-with-a-buy-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/madrigal-pharmaceuticals-initiated-with-a-buy-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","MDGL","BK4588","LU2324357040.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668277859","title":"Madrigal Pharmaceuticals management to meet with Oppenheimer","url":"https://stock-news.laohu8.com/highlight/detail?id=2668277859","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668277859?lang=en_us&edition=fundamental","pubTime":"2026-09-19 01:25","pubTimestamp":1789752316,"startTime":"0","endTime":"0","summary":"Meeting to be held in Dallas on September 25 hosted by Oppenheimer. Published first on TheFly – the ultimate source for real-time, market-moving br...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/madrigal-pharmaceuticals-management-to-meet-with-oppenheimer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/madrigal-pharmaceuticals-management-to-meet-with-oppenheimer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDGL","LU2324357040.USD","BK4588","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668593397","title":"Madrigal Grants Inducement Equity Awards to 27 New Hires, Including 2,754 Stock Options Priced at USD 538.71","url":"https://stock-news.laohu8.com/highlight/detail?id=2668593397","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668593397?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:05","pubTimestamp":1789589141,"startTime":"0","endTime":"0","summary":"Madrigal grants inducement equity awards to 27 new hires, including 2,754 stock options priced at USD 538.71Madrigal Pharmaceuticals granted inducement equity awards to 27 new non-executive employees ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL73JY9R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDGL","BK4585","SG9999014039.USD","IE00BQXX3F31.USD","LU2324357040.USD","BK4112","IE00BN0W2T93.GBP","BK4139","BK4588","IE00B3QW5Z07.USD","NDAQ","IE00BQXX3D17.EUR","IE00BN0W2W23.USD","LU2210150020.SGD","IE00BQXX3C00.GBP","SG9999014005.SGD","IE00BGHQF748.EUR","BCDF","IE00B64PRP62.GBP","LU0314104364.USD","SG9999014013.SGD","SG9999014021.USD","LU2095319765.USD","IE00BN0W2V16.EUR","LU2210149790.SGD","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668933929","title":"Madrigal Pharmaceuticals Announces Grants of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668933929","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668933929?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:05","pubTimestamp":1789589100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nTUA494LMV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","BK4588","BK4585","BK4139","MDGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668353529","title":"Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668353529","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668353529?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:05","pubTimestamp":1789589100,"startTime":"0","endTime":"0","summary":"CONSHOHOCKEN, Pa., Sept.  16, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-asso","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/16/3363532/0/en/madrigal-pharmaceuticals-announces-grants-of-inducement-awards-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","BK4585","BK4588","BK4139","LCLG","MDGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666742885","title":"Madrigal Pharma CEO William John Sibold Disposes of Common Shares Worth $4.16 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666742885","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666742885?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:57","pubTimestamp":1789160277,"startTime":"0","endTime":"0","summary":"Madrigal Pharma CEO William John Sibold disposes of common shares worth $4.16 millionMadrigal Pharmaceuticals President and CEO William John Sibold sold 11,193 common shares on Sep. 9-11.Prices ranged","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL6X3wS0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Madrigal Pharma CEO William John Sibold Disposes of Common Shares Worth $4.16 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","MDGL","BK4585","LU2324357040.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664819259","title":"Madrigal Pharmaceuticals to Present at Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664819259","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664819259?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:02","pubTimestamp":1788350544,"startTime":"0","endTime":"0","summary":"Madrigal Pharmaceuticals to present at Cantor Global Healthcare ConferenceMadrigal Pharmaceuticals will participate in the 2026 Cantor Global Healthcare Conference on Sept. 10, 2026.Management present","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL8WwsvZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","SG9999014039.USD","BK4112","IE00BKPKM429.USD","SG9999014021.USD","LU2210150020.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","BCDF","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","BK4139","LU0314104364.USD","BK4585","IE00BN0W2T93.GBP","MDGL","IE00BQXX3D17.EUR","NDAQ","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4588","LU2324357040.USD","LU2210149790.SGD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663013958","title":"Can Madrigal Pharmaceuticals (MDGL) Still Offer Value After Its Big Run?","url":"https://stock-news.laohu8.com/highlight/detail?id=2663013958","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663013958?lang=en_us&edition=fundamental","pubTime":"2026-08-29 03:28","pubTimestamp":1787945292,"startTime":"0","endTime":"0","summary":"Madrigal Pharmaceuticals has delivered very strong long term share price gains, yet the current valuation checks still lean toward the stock looking cheap on the broader scorecard. That combination raises questions for investors trying to judge whether recent trading levels already reflect the progress in the business.\n\nOver the past 5 years, Madrigal Pharmaceuticals has produced a very large total return, which puts extra focus on whether today’s price still leaves room for further value...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mdgl/madrigal-pharmaceuticals/news/can-madrigal-pharmaceuticals-mdgl-still-offer-value-after-it","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mdgl/madrigal-pharmaceuticals/news/can-madrigal-pharmaceuticals-mdgl-still-offer-value-after-it","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4139","MDGL","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157140095","title":"Movement Alert｜Madrigal Pharmaceuticals Rises 5.08% in Regular Trading, Trading at $537.92","url":"https://stock-news.laohu8.com/highlight/detail?id=1157140095","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157140095?lang=en_us&edition=fundamental","pubTime":"2026-08-27 03:02","pubTimestamp":1787770920,"startTime":"0","endTime":"0","summary":"On August 27, Madrigal Pharmaceuticals rose 5.08% in regular trading, trading at $537.92/share, with Turnover of $124 million.Within the Biotechnology sector where Madrigal Pharmaceuticals belongs,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDGL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661623473","title":"Madrigal Grants 4,676 Inducement RSUs to 13 New Employees Under 2025 Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2661623473","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661623473?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:05","pubTimestamp":1787256346,"startTime":"0","endTime":"0","summary":"Madrigal grants 4,676 inducement RSUs to 13 new employees under 2025 planMadrigal Pharmaceuticals granted equity inducement awards to 13 new non-executive employees under its 2025 Inducement Plan.Awar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL3ndytG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BKPKM429.USD","SG9999014039.USD","LU0314104364.USD","IE00BN0W2W23.USD","IE00BQXX3F31.USD","LU2095319765.USD","LU2210149790.SGD","IE00BQXX3C00.GBP","SG9999014021.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4139","BCDF","BK4585","SG9999014005.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","NDAQ","BK4112","IE00BN0W2V16.EUR","IE00BQXX3D17.EUR","MDGL","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661234243","title":"Madrigal Pharmaceuticals Announces Grants of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661234243","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661234243?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:05","pubTimestamp":1787256300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nTUA9L43MM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","MDGL","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232636","title":"Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232636","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232636?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:05","pubTimestamp":1787256300,"startTime":"0","endTime":"0","summary":"CONSHOHOCKEN, Pa., Aug.  20, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-assoc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/20/3348794/0/en/madrigal-pharmaceuticals-announces-grants-of-inducement-awards-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LCLG","MDGL","BK4139","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660476475","title":"Madrigal Pharmaceuticals (MDGL) Stock May Look Cheap On Sales But Risky On Cash Flow","url":"https://stock-news.laohu8.com/highlight/detail?id=2660476475","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660476475?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:27","pubTimestamp":1787171221,"startTime":"0","endTime":"0","summary":"Madrigal Pharmaceuticals stock has pulled back in recent weeks after a very strong multi year run, which leaves investors asking whether the current price still looks attractive based on the broader valuation checks.\n\nOver the past 5 years the share price has delivered a very large gain of about 5.4x, which means even small changes in expectations can now matter much more for valuation.\nFuture expectations for Madrigal Pharmaceuticals often hinge on how successfully it can convert its...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mdgl/madrigal-pharmaceuticals/news/madrigal-pharmaceuticals-mdgl-stock-may-look-cheap-on-sales","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mdgl/madrigal-pharmaceuticals/news/madrigal-pharmaceuticals-mdgl-stock-may-look-cheap-on-sales","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MDGL"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.madrigalpharma.com","stockEarnings":[{"period":"1week","weight":-0.0554},{"period":"1month","weight":-0.137},{"period":"3month","weight":-0.121},{"period":"6month","weight":-0.0921},{"period":"1year","weight":0.1014},{"period":"ytd","weight":-0.1899}],"compareEarnings":[{"period":"1week","weight":0.0116},{"period":"1month","weight":0.0212},{"period":"3month","weight":0.0313},{"period":"6month","weight":0.1459},{"period":"1year","weight":0.16},{"period":"ytd","weight":0.1417}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor beta agonist, which is in Phase III clinical trials for treating NASH. The company is also developing MGL-3745, a backup compound to resmetirom. The company is headquartered in West Conshohocken, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.018335},{"month":2,"riseRate":0.7,"avgChangeRate":0.060749},{"month":3,"riseRate":0.3,"avgChangeRate":-0.012858},{"month":4,"riseRate":0.5,"avgChangeRate":0.006598},{"month":5,"riseRate":0.3,"avgChangeRate":0.113604},{"month":6,"riseRate":0.7,"avgChangeRate":0.037265},{"month":7,"riseRate":0.1,"avgChangeRate":-0.084013},{"month":8,"riseRate":0.636364,"avgChangeRate":0.102406},{"month":9,"riseRate":0.363636,"avgChangeRate":0.10692},{"month":10,"riseRate":0.545455,"avgChangeRate":0.043904},{"month":11,"riseRate":0.6,"avgChangeRate":0.099039},{"month":12,"riseRate":0.4,"avgChangeRate":0.372201}],"exchange":"NASDAQ","name":"Madrigal Pharmaceuticals","nameEN":"Madrigal Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Madrigal Pharmaceuticals(MDGL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Madrigal Pharmaceuticals(MDGL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Madrigal Pharmaceuticals,MDGL,Madrigal Pharmaceuticals股票,Madrigal Pharmaceuticals股票老虎,Madrigal Pharmaceuticals股票老虎国际,Madrigal Pharmaceuticals行情,Madrigal Pharmaceuticals股票行情,Madrigal Pharmaceuticals股价,Madrigal Pharmaceuticals股市,Madrigal Pharmaceuticals股票价格,Madrigal Pharmaceuticals股票交易,Madrigal Pharmaceuticals股票购买,Madrigal Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Madrigal Pharmaceuticals(MDGL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Madrigal Pharmaceuticals(MDGL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction